These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 24375064)

  • 1. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
    Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of sCD30 and sCD40L in patients with malignant bone tumours.
    Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
    Wien Med Wochenschr; 2003; 153(1-2):40-2. PubMed ID: 12621691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma.
    Trieb K; Gerth R; Windhager R; Grohs JG; Holzer G; Berger P; Kotz R
    Immunobiology; 2000 Jan; 201(3-4):368-76. PubMed ID: 10776793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone sarcomas].
    Pieper M; Daum R
    Monatsschr Kinderheilkd (1902); 1975 May; 123(5):384-7. PubMed ID: 768748
    [No Abstract]   [Full Text] [Related]  

  • 8. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors.
    Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
    Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demographic Analysis of Patients with Osteosarcoma, Chonddrosarcoma, Ewing's Sarcoma from one Sarcoma Center in Switzerland].
    Hodel S; Seeli F; Fuchs B
    Praxis (Bern 1994); 2015 Jun; 104(13):673-80. PubMed ID: 26081379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of primary malignant bone tumors.
    Bloem JL; Bluemm RG; Taminiau AH; van Oosterom AT; Stolk J; Doornbos J
    Radiographics; 1987 May; 7(3):425-45. PubMed ID: 3482329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
    Jiang L; Liu J; Wei Q; Wang Y
    Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance in serum soluble CD30/CD30L and CD40/CD40L systems are associated with ovarian tumors.
    Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Hauza G
    Hum Immunol; 2013 Jan; 74(1):70-4. PubMed ID: 23073297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
    Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
    BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects and diagnosis of primary malignant bone neoplasms].
    Trapeznikov NN; Eremina LA
    Voen Med Zh; 1972 Feb; 2():27-33. PubMed ID: 4508847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant bone tumors of the hand].
    Schnürer S; Horch RE
    Handchir Mikrochir Plast Chir; 2013 Jun; 45(3):152-8. PubMed ID: 23860700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interdisciplinary diagnostic and treatment of bone sarcomas of the extremities and trunk].
    Andreou D; Hardes J; Gosheger G; Henrichs MP; Nottrott M; Streitbürger A
    Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):90-9. PubMed ID: 25897578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of imaging of malignant bone tumors in children and young adults.
    Rana KA; Meyer J; Ibrahim S; Ralls M; Kent PM
    Curr Probl Cancer; 2013; 37(4):181-91. PubMed ID: 24238583
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Hardes J; Gosheger G; Budny T
    Z Orthop Unfall; 2018 Feb; 156(1):105-124. PubMed ID: 29471560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy.
    Aran V; Devalle S; Meohas W; Heringer M; Cunha Caruso A; Pinheiro Aguiar D; Leite Duarte ME; Moura Neto V
    Crit Rev Oncol Hematol; 2021 Jun; 162():103340. PubMed ID: 33894338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
    Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.